永利3044(中国集团)有限公司官网

分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Bifidobacterium bifidum Ameliorates DSS-Induced Colitis in Mice by Regulating AHR/NRF2/NLRP3 Inflammasome Pathways through Indole-3-lactic Acid Production

Qingyu Cui, Zhe Zhang, Xiaoying Tian, Xi Liang, Youyou Lu, Yixin Shi, Malina Kuerman, Rui Wang, Yu zhou, Pimin Gong, Kai Lin, Huaxi Yi, Jiadong Li, Tongjie Liu, Lanwei Zhang

Journal:JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

IF:6.1

DOI:10.1021/acs.jafc.2c06894

PMID:36633059

Published:2023-01-12

research field:肿瘤学分子生物学遗传学

Abstract

In this study, the effectors and mechanisms of Bifidobacterium bifidum FL-276.1 and B. bifidum FL-228.1 in alleviating dextran sulfate sodium (DSS)-induced colitis were investigated. Both FL-276.1 and FL-228.1 significantly alleviated DSS-induced colitis, whether they were supplemented from the beginning of the experiment (whole course intervention) or after the DSS induction started (partial intervention). Aryl hydrocarbon receptor (AHR) and the nuclear factor erythroid 2-related factor 2 (NRF2) pathways were activated in mice colons, while the NLR family pyrin domain containing 3 (NLRP3) was downregulated under the whole course intervention modes. Indole-3-lactic acid, an AHR ligand produced by FL-276.1 and FL-228.1, could regulate the AHR/NRF2/NLRP3 pathway in Caco-2 monolayers, thus upregulating the tight junction proteins and protecting the integrity of the epithelial barrier. These results are conducive to promoting clinical trials and product development of probiotics for alleviating colitis.

本文使用的Yeasen产品

推荐应用
购物车
客服
转染试用
XML 地图